Get the Stockscreener App
2.74
9.87%
-0.30
After Hours:
2.90
0.16
+5.84%
Lexeo Therapeutics Inc Stock (LXEO) Forecast
The Lexeo Therapeutics Inc (LXEO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.0084, representing a +119.28% increase from the current price of $2.74. The highest analyst price target is $9.8488, and the lowest is $2.168.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LXEO Price Target
Average 8.4196
(+207.29% Upside)
Is Lexeo Therapeutics Inc (LXEO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.43 | Buy |
| STOCH(9,6) | 26.58 | Neutral |
| STOCHRSI(14) | 24.91 | Neutral |
| MACD(12,26) | -0.3595 | Sell |
| ADX(14) | 29.40 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -70.79 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.277
Sell
|
3.2236
Sell
|
| MA20 |
3.512
Sell
|
3.5039
Sell
|
| MA50 |
4.2566
Sell
|
4.021
Sell
|
| MA100 |
4.4705
Sell
|
4.5346
Sell
|
| MA200 |
5.6344
Sell
|
5.1219
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, LXEO could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on LXEO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.43 indicates that LXEO is oversold. This indicates that LXEO price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 26.58 indicates that LXEO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 24.91 indicates that LXEO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.4 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -70.79 indicates that LXEO is still oversold but not to an extreme extent.
Long-term LXEO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lexeo Therapeutics Inc financial reports and earnings history, Lexeo Therapeutics Inc (LXEO) stock could reach $2.1181 by 2030, $29.05 by 2040 and $53.17 by 2050. See the projected annual prices until 2050 of the Lexeo Therapeutics Inc stock below:
- Lexeo Therapeutics Inc (LXEO) is expected to reach an average price of $11.25 in 2035, with a high prediction of $12.85 and a low estimate of $11.88. This indicates an $310.49% rise from the last recorded price of $2.74.
- Lexeo Therapeutics Inc (LXEO) stock is projected to chart a bullish course in 2040, with an average price target of $29.01, representing an $958.64% surge from its current level. The forecast ranges from a conservative $5.2949 to a sky-high $29.05.
- Our analysts predict Lexeo Therapeutics Inc (LXEO) to jump 866.82% by 2045, soaring from $26.27 to an average price of $26.49, potentially reaching $26.78. While $26.27 is the low estimate, the potential upside is significant.
- Lexeo Therapeutics Inc (LXEO) stock is expected to climb by 2050, reaching an average of $47.86, a $1,647% jump from its current level. However, a wide range of estimates exists, with high and low targets of $53.17 and $50.10, respectively, highlighting the market's uncertainty.
Lexeo Therapeutics Inc Stock (LXEO) Year by Year Forecast
Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2026
The predicted value for Lexeo Therapeutics Inc (LXEO) in 2026 is set at an average of $6.015. Estimates vary from a peak of $10.75 to a trough of $1.28, indicating an +119.53% surge from the present price of $2.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $4.678 | $2.168 | $9.8488 | +70.73% |
| December, 2026 | $7.9166 | $4.4804 | $9.2873 | +188.93% |
Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lexeo Therapeutics Inc (LXEO) is $7.4135, with a high forecast of $14.67 and a low forecast of $0.1556. This indicates an +170.56% increase from the last price of $2.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.4453 | $6.3513 | $14.67 | +244.72% |
| February, 2027 | $7.2039 | $6.7339 | $10.01 | +162.92% |
| March, 2027 | $8.4372 | $4.9632 | $9.7979 | +207.93% |
| April, 2027 | $5.3959 | $4.4312 | $8.8119 | +96.93% |
| May, 2027 | $8.5292 | $4.9305 | $9.7898 | +211.28% |
| June, 2027 | $9.4078 | $7.6338 | $12.31 | +243.35% |
| July, 2027 | $4.5365 | $4.2465 | $12.81 | +65.56% |
| August, 2027 | $5.7298 | $4.4498 | $7.0804 | +109.12% |
| September, 2027 | $3.3284 | $3.2084 | $6.3144 | +21.47% |
| October, 2027 | $2.4571 | $2.1871 | $4.5731 | -10.33% |
| November, 2027 | $1.9004 | $1.4757 | $5.197 | -30.64% |
| December, 2027 | $2.339 | $0.1556 | $5.7597 | -14.63% |
Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2028
In 2028, Lexeo Therapeutics Inc (LXEO) is projected to reach an average price of $2.7622, with a high projection of $5.5014 and a low estimate of $0.023. This indicates an +0.81% rise from the last price of $2.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8623 | $0.023 | $2.8837 | -68.53% |
| February, 2028 | $0.000966 | $0.4516 | $2.0116 | -99.96% |
| March, 2028 | $1.5504 | $0.3644 | $0.7205 | -43.42% |
| April, 2028 | $2.5917 | $2.5807 | $2.4211 | -5.41% |
| May, 2028 | $2.4184 | $1.7824 | $2.5231 | -11.74% |
| June, 2028 | $2.2998 | $1.1445 | $1.3138 | -16.07% |
| July, 2028 | $0.8765 | $0.9715 | $1.8058 | -68.01% |
| August, 2028 | $0.2278 | $0.7526 | $0.5331 | -91.68% |
| September, 2028 | $0.1908 | $0.2832 | $0.5202 | -93.04% |
| October, 2028 | $0.4241 | $0.1079 | $0.7145 | -84.52% |
| November, 2028 | $2.5428 | $0.3688 | $3.1728 | -7.20% |
| December, 2028 | $5.4914 | $2.1671 | $5.5014 | +100.42% |
Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2029
The 2029 price forecast for Lexeo Therapeutics Inc Stock (LXEO) is $4.236 on average, with a high prediction of $7.248 and a low estimate of $1.2239. This represents an +54.60% increase from the previous price of $2.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.1447 | $3.6754 | $6.3607 | +87.76% |
| February, 2029 | $6.5734 | $4.454 | $7.0134 | +139.90% |
| March, 2029 | $6.902 | $5.2574 | $7.248 | +151.90% |
| April, 2029 | $2.8453 | $2.8253 | $5.9967 | +3.84% |
| May, 2029 | $3.334 | $2.545 | $4.674 | +21.68% |
| June, 2029 | $2.5326 | $1.7879 | $3.5986 | -7.57% |
| July, 2029 | $2.7559 | $2.3823 | $3.8969 | +0.58% |
| August, 2029 | $2.2646 | $1.5249 | $3.4852 | -17.35% |
| September, 2029 | $2.0132 | $1.2239 | $2.5685 | -26.53% |
| October, 2029 | $2.0965 | $1.6625 | $2.7472 | -23.48% |
| November, 2029 | $2.4552 | $1.4958 | $2.9802 | -10.40% |
| December, 2029 | $1.9485 | $1.7585 | $2.7398 | -28.89% |
Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2030
Lexeo Therapeutics Inc Stock (LXEO) is expected to reach an average price of $3.5455 in 2030, with a high forecast of $7.0126 and a low forecast of $0.0785. This signifies an +29.40% surge from the last price of $2.74.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1171 | $0.7978 | $2.1181 | -59.23% |
| February, 2030 | $4.6414 | $0.6618 | $4.9315 | +69.39% |
| March, 2030 | $3.1541 | $2.6927 | $2.482 | +15.11% |
| April, 2030 | $1.0126 | $1.3074 | $7.0126 | -63.05% |
| May, 2030 | $1.4998 | $0.4712 | $2.6112 | -45.26% |
| June, 2030 | $0.1071 | $0.0785 | $2.2768 | -96.09% |
| July, 2030 | $1.4262 | $0.1699 | $2.4858 | -47.95% |
| August, 2030 | $1.689 | $2.139 | $1.7176 | -38.36% |
| September, 2030 | $2.8377 | $0.3817 | $3.0077 | +3.56% |
| October, 2030 | $2.525 | $0.135 | $5.4863 | -7.85% |
| November, 2030 | $1.7378 | $0.3343 | $6.1236 | -36.58% |
| December, 2030 | $0.8411 | $0.7631 | $0.5309 | -69.30% |
4.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):